This is the authors' abstract. We don't add key points for this paper.
In the first nationally representative U.S. estimates, we found substantial socioeconomic and race/ethnic differences in the seroprevalence of EBV across all ages for U.S. children and adolescents. These estimates can help researchers and clinicians identify groups most at risk, inform research on EBV-cancer etiology, and motivate potential vaccine development.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dowd et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: